======= BACE2 ======= == Gene Information == * **Official Symbol**: BACE2 * **Official Name**: beta-secretase 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=25825|25825]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y5Z0|Q9Y5Z0]] * **Interactions**: [[https://thebiogrid.org/search.php?search=BACE2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20BACE2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/605668|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Responsible for the proteolytic processing of the amyloid precursor protein (APP). Cleaves APP, between residues 690 and 691, leading to the generation and extracellular release of beta-cleaved soluble APP, and a corresponding cell-associated C- terminal fragment which is later released by gamma-secretase. It has also been shown that it can cleave APP between residues 671 and 672. {ECO:0000269|PubMed:10591213, ECO:0000269|PubMed:11083922, ECO:0000269|PubMed:11423558, ECO:0000269|PubMed:15857888, ECO:0000269|PubMed:16816112}. |Asp| |negative regulation of amyloid precursor protein biosynthetic process| |regulation of amyloid precursor protein biosynthetic process| |negative regulation of glycoprotein biosynthetic process| |dense core granule| |negative regulation of glycoprotein metabolic process| |astrocyte activation| |amyloid-beta metabolic process| |aspartic-type endopeptidase activity| |membrane protein ectodomain proteolysis| |peptide hormone processing| |astrocyte development| |membrane protein proteolysis| |glial cell activation| |regulation of glycoprotein biosynthetic process| |neuroinflammatory response| |regulation of glycoprotein metabolic process| |astrocyte differentiation| |amyloid-beta binding| |glial cell development| |protein processing| |trans-Golgi network| |glial cell differentiation| |glucose homeostasis| |carbohydrate homeostasis| |hormone metabolic process| |gliogenesis| |protein maturation| |endosome| |inflammatory response| |peptide metabolic process| |regulation of hormone levels| |protein catabolic process| |cellular amide metabolic process| |central nervous system development| |Golgi apparatus| |endoplasmic reticulum| |macromolecule catabolic process| |organonitrogen compound catabolic process| |cell activation| |negative regulation of protein metabolic process| |chemical homeostasis| |proteolysis| |defense response| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |neurogenesis| |homeostatic process| |cell development| |organic substance catabolic process| |membrane| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp335|Aminopterin 0.005μM R07 exp335]]|1.93| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 12713 * **Expression level (log2 read counts)**: 1.16 {{:chemogenomics:nalm6 dist.png?nolink |}}